P R Carr1, E Alwers1, S Bienert1, J Weberpals1, M Kloor2, H Brenner1,3,4, M Hoffmeister1. 1. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. 2. Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany. 3. Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. 4. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract
Introduction: The association of lifestyle factors with molecular pathological subtypes of colorectal cancer (CRC), such as microsatellite instability (MSI), could provide further knowledge about the colorectal carcinogenic process. The aim of this review was to evaluate possible associations between lifestyle factors and risk of sporadic CRC by MSI status. Methods: PubMed and Web of Science were searched for studies investigating the association between alcohol, body mass index, dietary fiber, hormone replacement therapy (HRT), non-steroidal anti-inflammatory drugs, physical activity, red meat, smoking, or statin use, with MSI-high (MSI-H) and microsatellite stable (MSS) CRC. Meta-analyses were carried out to calculate summary relative risks (sRR). Results: Overall, 31 studies reporting on the association between lifestyle factors and CRC according to MSI status were included in this review. Ever smoking was associated with MSI-H (sRR = 1.62; 95% CI: 1.40-1.88) and MSS/MSI-low CRC (sRR = 1.10; 95% CI: 1.01-1.20), but the association was significantly stronger for MSI-H CRC. The use of HRT was associated with a 20% decrease (sRR = 0.80; 95% CI: 0.73-0.89) in the risk of MSS CRC, but was not associated with MSI-H CRC. An increase in body mass index per 5 kg/m2 was equally associated with MSS and MSI-H CRC (sRR = 1.22, in both cases), but was statistically significant for MSS CRC only (95% CI: 1.11-1.34 and 0.94-1.58, respectively). Limited evidence for associations between other lifestyle factors and CRC by MSI status exists. Conclusions: Lifestyle factors, such as HRT and smoking are differentially associated with the risk of MSI-H and MSS CRC. Further research on associations of lifestyle factors and CRC subtypes is necessary to provide a better understanding of the CRC disease pathway.
Introduction: The association of lifestyle factors with molecular pathological subtypes of colorectal cancer (CRC), such as microsatellite instability (MSI), could provide further knowledge about the colorectal carcinogenic process. The aim of this review was to evaluate possible associations between lifestyle factors and risk of sporadic CRC by MSI status. Methods: PubMed and Web of Science were searched for studies investigating the association between alcohol, body mass index, dietary fiber, hormone replacement therapy (HRT), non-steroidal anti-inflammatory drugs, physical activity, red meat, smoking, or statin use, with MSI-high (MSI-H) and microsatellite stable (MSS) CRC. Meta-analyses were carried out to calculate summary relative risks (sRR). Results: Overall, 31 studies reporting on the association between lifestyle factors and CRC according to MSI status were included in this review. Ever smoking was associated with MSI-H (sRR = 1.62; 95% CI: 1.40-1.88) and MSS/MSI-low CRC (sRR = 1.10; 95% CI: 1.01-1.20), but the association was significantly stronger for MSI-H CRC. The use of HRT was associated with a 20% decrease (sRR = 0.80; 95% CI: 0.73-0.89) in the risk of MSS CRC, but was not associated with MSI-H CRC. An increase in body mass index per 5 kg/m2 was equally associated with MSS and MSI-H CRC (sRR = 1.22, in both cases), but was statistically significant for MSS CRC only (95% CI: 1.11-1.34 and 0.94-1.58, respectively). Limited evidence for associations between other lifestyle factors and CRC by MSI status exists. Conclusions: Lifestyle factors, such as HRT and smoking are differentially associated with the risk of MSI-H and MSS CRC. Further research on associations of lifestyle factors and CRC subtypes is necessary to provide a better understanding of the CRC disease pathway.
Authors: Tsuyoshi Hamada; Jonathan A Nowak; Yohei Masugi; David A Drew; Mingyang Song; Yin Cao; Keisuke Kosumi; Kosuke Mima; Tyler S Twombly; Li Liu; Yan Shi; Annacarolina da Silva; Mancang Gu; Wanwan Li; Katsuhiko Nosho; NaNa Keum; Marios Giannakis; Jeffrey A Meyerhardt; Kana Wu; Molin Wang; Andrew T Chan; Edward L Giovannucci; Charles S Fuchs; Reiko Nishihara; Xuehong Zhang; Shuji Ogino Journal: J Natl Cancer Inst Date: 2019-01-01 Impact factor: 13.506
Authors: Prudence R Carr; Barbara L Banbury; Sonja I Berndt; Peter T Campbell; Jenny Chang-Claude; Richard B Hayes; Barbara V Howard; Lina Jansen; Eric J Jacobs; Dorothy S Lane; Reiko Nishihara; Shuji Ogino; Amanda I Phipps; Martha L Slattery; Marcia L Stefanick; Robert Wallace; Viola Walter; Emily White; Kana Wu; Ulrike Peters; Andrew T Chan; Polly A Newcomb; Hermann Brenner; Michael Hoffmeister Journal: Clin Gastroenterol Hepatol Date: 2018-11-23 Impact factor: 11.382
Authors: Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Danny A Milner; Reiko Nishihara Journal: Annu Rev Pathol Date: 2018-08-20 Impact factor: 23.472
Authors: Akihisa Hidaka; Tabitha A Harrison; Yin Cao; Lori C Sakoda; Richard Barfield; Marios Giannakis; Mingyang Song; Amanda I Phipps; Jane C Figueiredo; Syed H Zaidi; Amanda E Toland; Efrat L Amitay; Sonja I Berndt; Ivan Borozan; Andrew T Chan; Steven Gallinger; Marc J Gunter; Mark A Guinter; Sophia Harlid; Heather Hampel; Mark A Jenkins; Yi Lin; Victor Moreno; Polly A Newcomb; Reiko Nishihara; Shuji Ogino; Mireia Obón-Santacana; Patrick S Parfrey; John D Potter; Martha L Slattery; Robert S Steinfelder; Caroline Y Um; Xiaoliang Wang; Michael O Woods; Bethany Van Guelpen; Stephen N Thibodeau; Michael Hoffmeister; Wei Sun; Li Hsu; Daniel D Buchanan; Peter T Campbell; Ulrike Peters Journal: Cancer Res Date: 2020-08-14 Impact factor: 12.701
Authors: Peter T Campbell; Yi Lin; Stephanie A Bien; Jane C Figueiredo; Tabitha A Harrison; Mark A Guinter; Sonja I Berndt; Hermann Brenner; Andrew T Chan; Jenny Chang-Claude; Steven J Gallinger; Susan M Gapstur; Graham G Giles; Edward Giovannucci; Stephen B Gruber; Marc Gunter; Michael Hoffmeister; Eric J Jacobs; Mark A Jenkins; Loic Le Marchand; Li Li; John R McLaughlin; Neil Murphy; Roger L Milne; Polly A Newcomb; Christina Newton; Shuji Ogino; John D Potter; Gad Rennert; Hedy S Rennert; Jennifer Robinson; Lori C Sakoda; Martha L Slattery; Yiqing Song; Emily White; Michael O Woods; Graham Casey; Li Hsu; Ulrike Peters Journal: J Natl Cancer Inst Date: 2021-01-04 Impact factor: 13.506
Authors: Naohiko Akimoto; Melissa Zhao; Tomotaka Ugai; Rong Zhong; Mai Chan Lau; Kenji Fujiyoshi; Junko Kishikawa; Koichiro Haruki; Kota Arima; Tyler S Twombly; Xuehong Zhang; Edward L Giovannucci; Kana Wu; Mingyang Song; Andrew T Chan; Yin Cao; Jeffrey A Meyerhardt; Kimmie Ng; Marios Giannakis; Juha P Väyrynen; Jonathan A Nowak; Shuji Ogino Journal: Cancers (Basel) Date: 2021-04-22 Impact factor: 6.639